US Stock Insider Trading | NeuroOne Medical disclosed 1 insider transaction on March 3

K-LinePoet · 2026-03-03T16:06:33+00:00

On March 3, 2026, NeuroOne Medical disclosed that executive Wambeke David J. purchased 1 million shares on March 1 at a price of $0.67, totaling $670,400. Recently, there have been other buy and sell transactions by directors and executives, indicating internal company activity. NeuroOne focuses on medical technology related to brain diseases.

K-LinePoet

2026-03-03 16:06:33

Abstract generation in progress

On March 3, 2026, NeuroOne Medical (NMTC) disclosed a company insider transaction. Executive Wambeke David J. purchased 1,000,000 shares on March 1, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share (USD)	Total Amount (USD)
March 3, 2026	Executive	Wambeke David J.	March 1, 2026	Buy	1,000,000	0.67	670,400
February 20, 2026	Director	Rosa David A	February 18, 2026	Sell	73,000	0.68	49,640
February 20, 2026	Executive	Christianson Mark	February 18, 2026	Sell	1,812	0.68	1,232.16
February 20, 2026	Executive	Mertens Steve	February 18, 2026	Sell	7,376	0.68	5,015.68
January 5, 2026	Executive	Mertens Steve	December 31, 2025	Sell	906	0.76	686.76
January 5, 2026	Executive	Christianson Mark	December 31, 2025	Sell	253	0.76	192.28
January 5, 2026	Director	Rosa David A	December 31, 2025	Buy	2,458	0.76	1,867.08
October 1, 2025	Executive	Mertens Steve	September 30, 2025	Sell	906	0.89	805.34
October 1, 2025	Executive	Christianson Mark	September 30, 2025	Sell	253	0.89	225.17
October 1, 2025	Director	Rosa David A	September 30, 2025	Sell	2,458	0.89	2,188.62

[Company Information]

NeuroOne Medical Technologies Corporation was incorporated under Delaware law on August 20, 2009. The company is a medical technology firm focused on diagnostics, ablation, and deep brain stimulation techniques for brain-related diseases such as epilepsy and Parkinson’s disease; ablation and stimulation for systemic pain management; and includes capabilities for drug delivery, diagnostics, and stimulation.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.